Expression system for high levels of GAG lyase gene expression and study of the hepA upstream region in Flavobacterium heparinum

被引:9
作者
Blain, F [1 ]
Tkalec, AL [1 ]
Shao, ZQ [1 ]
Poulin, C [1 ]
Pedneault, M [1 ]
Gu, KF [1 ]
Eggimann, B [1 ]
Zimmermann, J [1 ]
Su, HS [1 ]
机构
[1] IBEX Pharmaceut Inc, Montreal, PQ H4P 1P7, Canada
关键词
D O I
10.1128/JB.184.12.3242-3252.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A system for high-level expression of heparinase I, heparinase II, heparinase III, chondroitinase AC, and chondroitinase B in Flavobacterium heparinum is described. hepA. along with its regulatory region, as well as hepB, hepC, cslA, and cslB, cloned downstream of the hepA regulatory region, was integrated in the chromosome to yield stable transconjugant strains. The level of heparinase I and II expression from the transconjugant strains was approximately fivefold higher, while heparinase III expression was 10-fold higher than in wild-type F. heparinum grown in heparin-only medium. The chondroitinase AC and B transconjugant strains, grown in heparin-only medium, yielded 20- and 13-fold increases, respectively, in chondroitinase AC and B expression, compared to wild-type F. heparinum grown in chondroitin sulfate A-only medium. The hepA upstream region was also studied using cslA as a reporter gene, and the transcriptional start site was determined to be 26 bp upstream of the start codon in the chondroitinase AC transconjugant strain, The transcriptional start sites were determined for hepA in both the wild-type F. heparinum and heparinase I transconjugant strains and were shown to be the same as in the chondroitinase AC transconjugant strain. The five GAG lyases were purified from these transconjugant strains and shown to be identical to their wild-type counterparts.
引用
收藏
页码:3242 / 3252
页数:11
相关论文
共 41 条
  • [1] BAUG RF, 1993, PERFUSION REV, V1, P14
  • [2] BOORSTEIN WR, 1989, METHOD ENZYMOL, V180, P347
  • [3] DESCRIPTION AND TAXONOMIC STATUS OF CYTOPHAGA-HEPARINA (PAYZA AND KORN) COMB NOV (BASIONYM, FLAVOBACTERIUM-HEPARINUM PAYZA AND KORN 1956)
    CHRISTENSEN, P
    [J]. INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1980, 30 (02): : 473 - 475
  • [4] Inhibition of human dermal fibroblast proliferation by removal of dermatan sulfate
    Denholm, EM
    Cauchon, E
    Poulin, C
    Silver, PJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 400 (2-3) : 145 - 153
  • [5] ENZYMATIC DEGRADATION OF GLYCOSAMINOGLYCANS
    ERNST, S
    LANGER, R
    COONEY, CL
    SASISEKHARAN, R
    [J]. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 30 (05) : 387 - 444
  • [6] Ernst S, 1997, BIOTECHNOL BIOENG, V53, P575, DOI 10.1002/(SICI)1097-0290(19970320)53:6<575::AID-BIT5>3.0.CO
  • [7] 2-J
  • [8] Crystal structure of chondroitin AC lyase, a representative of a family of glycosaminoglycan degrading enzymes
    Féthière, J
    Eggimann, B
    Cygler, M
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1999, 288 (04) : 635 - 647
  • [9] Crystallization and preliminary analysis of chondroitinase AC from Flavobacterium heparinum
    Fethiere, J
    Shilton, BH
    Li, YG
    Allaire, M
    Laliberte, M
    Eggimann, B
    Cygler, M
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 : 279 - 280
  • [10] HEPARINASE PRODUCTION BY FLAVOBACTERIUM-HEPARINUM
    GALLIHER, PM
    COONEY, CL
    LANGER, R
    LINHARDT, RJ
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1981, 41 (02) : 360 - 365